Premium
CD40 activation is angioproliferative in pulmonary microvascular endothelial cells
Author(s) -
Baker Jeffrey T,
Moore Timothy M
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.23.1_supplement.771.7
Subject(s) - cd40 , progenitor cell , microbiology and biotechnology , cancer research , biology , chemistry , stem cell , in vitro , biochemistry , cytotoxic t cell
Endothelial CD40 is important during inflammation as an angiogenic stimulus. We tested whether CD40 expression in PMVEC is associated with angioproliferative potential. Methods Western analysis for CD40 expression was performed. Growth curves, barrier measurements, and scratch‐wound assays were carried out using an ECIS apparatus (Applied Biophysics) and a digital image system composed of an inverted microscope. Results Basal CD40 expression was high in PMVEC, whereas expression was absent in rat pulmonary arterial‐derived EC (PAEC). CD40 expression could be up‐regulated in PAEC following over‐expression of NAP‐1, an endothelial progenitor cell‐associated protein. Exposure of PMVEC to sCD40L (1 μg/mL) for 1 ‐ 48 hours increased proliferation and improved barrier integrity. Exposure to sCD40L also produced an accelerated PMVEC migration response with decreased wound closure times. These effects were inhibited by pre‐treatment with anti‐CD40 antibodies. Conclusions Our data indicate activation of PMVEC‐expressed CD40 results in angioproliferative responses. These responses may be inherent to cell phenotypes expressing NAP‐1. Identification of PMVEC expressing CD40 in situ may localize pulmonary resident endothelial progenitor cells. Support: Parker B. Francis Foundation and AHA (0765421B) to T.M.M.